These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11584770)

  • 1. First AIDS vaccine trials next year.
    Bateman C
    S Afr Med J; 2001 Aug; 91(8):622-3. PubMed ID: 11584770
    [No Abstract]   [Full Text] [Related]  

  • 2. New hope for an AIDS vaccine.
    Robinson HL
    Nat Rev Immunol; 2002 Apr; 2(4):239-50. PubMed ID: 12001995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IAVI begins trials of AIDS vaccine.
    Expert Rev Vaccines; 2003 Dec; 2(6):731. PubMed ID: 15282843
    [No Abstract]   [Full Text] [Related]  

  • 4. Should South Africa be preparing for HIV-1 vaccine efficacy trials?
    Morris L; van der Ryst E; Gray C; Williamson C
    S Afr Med J; 1997 Mar; 87(3):285-90. PubMed ID: 9137338
    [No Abstract]   [Full Text] [Related]  

  • 5. [AIDS vaccine: who should be selected for the test?].
    Marcus U
    Fortschr Med; 1995 Nov; 113(32):16-7. PubMed ID: 8543269
    [No Abstract]   [Full Text] [Related]  

  • 6. Call for volunteers for AIDS vaccine trials.
    Expert Rev Vaccines; 2004 Jun; 3(3):232. PubMed ID: 15278963
    [No Abstract]   [Full Text] [Related]  

  • 7. Race on for local AIDS vaccine.
    Jones JS
    S Afr Med J; 1999 Jun; 89(6):582. PubMed ID: 10443198
    [No Abstract]   [Full Text] [Related]  

  • 8. AIDS research. More woes for struggling HIV vaccine field.
    Cohen J
    Science; 2013 May; 340(6133):667. PubMed ID: 23661729
    [No Abstract]   [Full Text] [Related]  

  • 9. 'Money down the drain' fears for AIDS vaccine trials.
    Nature; 2003 Nov; 426(6964):220-1. PubMed ID: 14628016
    [No Abstract]   [Full Text] [Related]  

  • 10. [There will not be an AIDS vaccine].
    Rozenbaum W
    Soins; 2004; (687):52. PubMed ID: 15384782
    [No Abstract]   [Full Text] [Related]  

  • 11. AIDS vaccination--insurance implications.
    Monday B
    S Afr Med J; 2002 Nov; 92(11):876-7. PubMed ID: 12506585
    [No Abstract]   [Full Text] [Related]  

  • 12. Research strategies for AIDS vaccine development and evaluation: the MRC programme.
    Karn J; Almond JW; Tyrrell DA
    AIDS; 1990; 4 Suppl 1():S167-78. PubMed ID: 2152562
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV vaccine trials for Africa.
    AIDS Read; 2000 Sep; 10(9):524. PubMed ID: 11019443
    [No Abstract]   [Full Text] [Related]  

  • 14. South African village prepares for first HIV vaccine trial.
    Connett H
    Nat Med; 2000 Nov; 6(11):1199-200. PubMed ID: 11062516
    [No Abstract]   [Full Text] [Related]  

  • 15. [1st AIDS Vaccine Study in Germany. German AIDS Foundation also finances the study].
    Kinderkrankenschwester; 2004 Jun; 23(6):236. PubMed ID: 16130918
    [No Abstract]   [Full Text] [Related]  

  • 16. In that case: your company has invested heavily in developing an AIDS vaccine and wishes to embark on clinical trials. Commentary.
    Evans D
    N Z Bioeth J; 2001 Oct; 2(3):37-8. PubMed ID: 15587008
    [No Abstract]   [Full Text] [Related]  

  • 17. What should South African HIV vaccine trials do about social harms?
    Milford C; Barsdorf N; Kafaar Z
    AIDS Care; 2007 Oct; 19(9):1110-7. PubMed ID: 18058395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why we don't need a relative risk standard for adolescent HIV vaccine trials in South Africa.
    Slack CM
    Am J Bioeth; 2011 Jun; 11(6):21-2. PubMed ID: 21678209
    [No Abstract]   [Full Text] [Related]  

  • 19. Is an effective HIV vaccine feasible?
    Cohen J
    Science; 2005 Jul; 309(5731):99. PubMed ID: 15994545
    [No Abstract]   [Full Text] [Related]  

  • 20. How should the potency of HIV vaccine candidates be determined?
    Sheets R; Bean P
    Am Clin Lab; 2000; 19(8):23. PubMed ID: 11146989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.